Phase 2 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a solid tumor (a type of cancer that forms a lump or mass) that did not start in the brain or spinal cord, and where the cancer has spread to other parts of the body, confirmed by scans or tissue testing
- People whose cancer has spread to the spine, as shown on medical imaging
- People where the affected area of the spine involves no more than 3 vertebrae (bones in the spine) that are next to each other
- People whose nervous system is working normally, or who have only minor weakness in their muscles (muscle strength rated 4 or 5 out of 5), whether or not they are taking steroid medication
- People who have been assessed by both a radiation oncology specialist and a spine surgeon or neurosurgeon
- People with a general health and activity level rated between 0 and 3 on a standard medical scale (where 0 means fully active and 3 means limited self-care ability) (confirm with trial site)
Who may not be able to join:
- People whose spine is considered unstable based on a specialist scoring system called the Spinal Instability Neoplastic Score (SINS), where a score above 12 indicates the spine may not be stable enough for this trial
- People who have already had surgery or radiation treatment directed at the specific area of the spine being studied in this trial
- People whose cancer type is known to respond well to standard radiation, such as small cell lung cancer, lymphoma, multiple myeloma, or germ-cell tumors
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kartik Mani, MD PhD, Stony Brook Cancer Center
Phone: 631-216-2990
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cumulative incidence of spinal surgery/stabilization within 6 months following SBRT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.